Why it matters:
This agreement marks a significant step towards advancing the country's position in the field of plasma medicine, which is crucial for improving healthcare services and adopting innovative medical technologies.
The big picture:
A tripartite cooperation agreement has been signed to emphasize the importance of developing new technologies in health and enhancing the country's status in plasma medicine. The agreement aims to foster extensive and multicenter research and clinical projects in plasma medicine, integrating this technology into the official treatment protocols of the country.
What they are saying:
Saeed Sarkar, the head of the Strategic Technology Development Center, Shahin Akhoundzadeh, the Deputy for Research and Technology at the Ministry of Health, Treatment, and Medical Education, and Mahdieh Bakhtiari, the CEO of the Plasma Technology Development Company, were the signatories of this agreement. They highlighted that the agreement symbolizes the synergy of the country's scientific, research, and technological capacities and will initiate a national movement to expand innovative technologies in the medical field.
Key points:
- The agreement focuses on developing and implementing extensive research and clinical projects in plasma medicine.
- It aims to integrate plasma technology into the country's official treatment protocols.
- This initiative is expected to play a significant role in treating difficult diseases and enhancing healthcare services.
- The agreement represents a collaborative effort to leverage the country's scientific and technological resources for national advancement in medical technology.
Go deeper:
Iranian Scientists Made Plasma Device Using SDBD
Zohre Khazaee - ahmad shirzadian
